Two siblings with fetal hydantoin syndrome

Turkish Journal of Pediatrics

Volumn 40, Issue 2, 1998, Pages 273-278

  Özkinay, Ferda ^a   Yenigün, Ayşe ^a   Kantar, Mehmet ^a   Özkinay, Cihangir ^a   Avanoǧlu, Ali ^a   Ulman, Ibrahim ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Craniofacial dysmorphism; Genital anomaly; Hydantoin; Phenobarbital; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; HYDANTOIN; PHENOBARBITAL; PHENYTOIN;

ARTICLE; CASE REPORT; CONVULSION; FEMALE; FETAL HYDANTOIN SYNDROME; GONADAL DYSGENESIS; GROWTH RETARDATION; HIRSUTISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; KARYOTYPE; MALE; PRESCHOOL CHILD; TERATOGENICITY; TOE MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ANTICONVULSANTS; CHILD, PRESCHOOL; CRANIOFACIAL ABNORMALITIES; EPILEPSY; FEMALE; GENITALIA, FEMALE; HUMANS; NAILS, MALFORMED; PHENYTOIN; PREGNANCY; PREGNANCY COMPLICATIONS; SYNDROME;

EID: 0031801168     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kaneko S, Otani K, Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988; 29: 459-467.
2. Lindhout D, Höppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984; 25: 77-83.
3. Jones KL, Lacro RV, Johnson KA, Adam J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320: 1661-1666.
4. Buehler BA, Delimont D, van Waes M, Finnel RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990; 322: 1567-1572.
5. Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediatr 1976; 87: 285-290.
6. Von Dyke DC, Hodge SE, Heide F, Hill LR. Family studies in fetal phenytoin exposure. J Pediatr 1988; 113: 301-306.
7. D'Souza SW, Robertson IG, Donnai D, Mawer G. Fetal phenytoin exposure, hypoplastic nails, and jitteriness. Arch Dis Child 1990; 66: 320-324.
8. Hanson JW, Mynanthopoulos NC, Harveys MA, Smith DW. Risks to the offspring of women treated with hydantoin anticonvulsants with emphasis on the fetal hydantoin syndrome. J Pediatr 1976; 89: 662-668.
9. Smith DW. Recognizable Patterns of Human Malformations. Philadelphia: WB Saunders; 1988: 495-497.
10. Strickler SM, Dansky LV, Miller MA, Seni MH, Andermann E, Spielberg SP. Genetic predisposition to phenytoin-induced birth defects. Lancet 1985; 2: 746-749.
11. Finell RH, Buehler BA, Kerr BM, Ager PL, Levy RH. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. Neurology 1992; 42: 25-31.